Publications by authors named "Judith Romero"

Claim this Profile
S
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study.
María Pascual-Lucas, Ana María Lacosta, María Montañés, Jesús Canudas, Jorge Loscos, Judith Romero

Alzheimers Dement· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment.
José Antonio Allué, Leticia Sarasa, Noelia Fandos, Ricardo Gonzalo, Rubén Sabido-Vera, Judith Romero

Front Aging Neurosci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition.
Shannon L Risacher, Noelia Fandos, Judith Romero, Ian Sherriff, Pedro Pesini

Alzheimers Dement (Amst)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
Virginia Pérez-Grijalba, Javier Arbizu, Judith Romero, Elena Prieto, Pedro Pesini

Alzheimers Res Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multichromophoric calix[4]arenes: effect of interchromophore distances on linear and nonlinear optical properties.
Raquel Andreu, Santiago Franco, Javier Garín, Judith Romero, Belén Villacampa

Chemphyschem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis